Petrus Trust Company’s Integra LifeSciences IART Stock Holding History

Petrus Trust Company’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,501	Closed	-$252K	–	336
2025 Q2	$252K	Buy	+20,501	New	+$298K	0.03%	391
2024 Q4	–	Sell	-24,304	Closed	-$442K	–	659
2024 Q3	$442K	Buy	+24,304	New	+$563K	0.04%	275
2024 Q2	–	Sell	-7,673	Closed	-$272K	–	665
2024 Q1	$272K	Buy	+7,673	New	+$307K	0.02%	477
2019 Q4	–	Sell	-4,934	Closed	-$296K	–	319
2019 Q3	$296K	Buy	4,934 +23	+0.5%	+$1.37K	0.05%	98
2019 Q2	$274K	Buy	+4,911	New	+$253K	0.05%	124
2018 Q4	–	Sell	-3,760	Closed	-$248K	–	257
2018 Q3	$248K	Buy	+3,760	New	+$234K	0.05%	142

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Petrus Trust Company's IART Position: Q3 2025 in Review

Petrus Trust Company sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 20,501 shares — an estimated $252K sold.

Petrus Trust Company first reported a position in IART in Q3 2018 and held it in 6 quarters. The position peaked at $442K in Q3 2024. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

Petrus Trust Company reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
Petrus Trust Company sold 20,501 Integra LifeSciences shares in Q3 2025, an estimated $252K.
Petrus Trust Company first reported a position in Integra LifeSciences in Q3 2018 and held it in 6 quarters.
Petrus Trust Company's Integra LifeSciences position peaked at $442K in Q3 2024.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.